Page last updated: 2024-11-04

sb 202190 and B16 Melanoma

sb 202190 has been researched along with B16 Melanoma in 3 studies

4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Ukiya, M1
Sato, D1
Kimura, H1
Hirai, Y1
Nishina, A1
Bellei, B1
Maresca, V1
Flori, E1
Pitisci, A1
Larue, L1
Picardo, M1
Kim, HA1
Kim, KJ1
Seo, KH1
Lee, HK1
Im, SY1

Other Studies

3 other studies available for sb 202190 and B16 Melanoma

ArticleYear
Tokoronin Contained in Dioscorea tokoro Makino ex Miyabe Suppressed α-MSH-Induced Melanogenesis in B16 Cells via Suppression of Classical MAPK Pathway Activation.
    Chemistry & biodiversity, 2020, Volume: 17, Issue:6

    Topics: alpha-MSH; Animals; Cell Line, Tumor; Cell Survival; Dioscorea; Down-Regulation; Extracellular Signa

2020
p38 regulates pigmentation via proteasomal degradation of tyrosinase.
    The Journal of biological chemistry, 2010, Mar-05, Volume: 285, Issue:10

    Topics: alpha-MSH; Animals; Enzyme Inhibitors; Enzyme Stability; Gene Expression Regulation; Humans; Imidazo

2010
PTEN/MAPK pathways play a key role in platelet-activating factor-induced experimental pulmonary tumor metastasis.
    FEBS letters, 2012, Dec-14, Volume: 586, Issue:24

    Topics: Androstadienes; Animals; Anthracenes; Butadienes; Cell Line; Humans; Imidazoles; Lung Neoplasms; MAP

2012